The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
The proposal would expand coverage of anti-obesity drugs to 7.5 million people covered by Medicare and Medicaid, the Biden ...
President Joe Biden’s proposal to have GLP-1 weight-loss drugs such as Ozempic and Mounjaro covered by Medicare and Medicaid ...
About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...
The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...
The Biden administration is proposing a new rule to significantly expand the coverage of weight-loss drugs for Americans on ...
Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by ...
About 7.4 million Americans with obesity could have insurance coverage for drugs like Wegovy if the Trump administration ...
The Biden administration called for Medicare and Medicaid to cover popular drugs that help people lose weight but are not ...
Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $ 35 ...
Proposal would let patients get Wegovy, Ozempic, related drugs for obesity, which is not a covered condition now.
WASHINGTON — Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound ...